These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 11511691)

  • 1. Immunohistochemical analyses of cell cycle-related proteins, apoptosis, and proliferation in pituitary adenomas.
    Nakabayashi H; Sunada I; Hara M
    J Histochem Cytochem; 2001 Sep; 49(9):1193-4. PubMed ID: 11511691
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of p27kip1 and Ki-67 in benign and malignant thyroid tumors.
    Erickson LA; Jin L; Wollan PC; Thompson GB; van Heerden J; Lloyd RV
    Mod Pathol; 1998 Feb; 11(2):169-74. PubMed ID: 9504687
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Low expression of the cell cycle inhibitor p27Kip1 in normal corticotroph cells, corticotroph tumors, and malignant pituitary tumors.
    Lidhar K; Korbonits M; Jordan S; Khalimova Z; Kaltsas G; Lu X; Clayton RN; Jenkins PJ; Monson JP; Besser GM; Lowe DG; Grossman AB
    J Clin Endocrinol Metab; 1999 Oct; 84(10):3823-30. PubMed ID: 10523037
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of phosphorylated p27(Kip1) protein and Jun activation domain-binding protein 1 in human pituitary tumors.
    Korbonits M; Chahal HS; Kaltsas G; Jordan S; Urmanova Y; Khalimova Z; Harris PE; Farrell WE; Claret FX; Grossman AB
    J Clin Endocrinol Metab; 2002 Jun; 87(6):2635-43. PubMed ID: 12050228
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reduced expression levels of the cell-cycle inhibitor p27Kip1 in human pituitary adenomas.
    Bamberger CM; Fehn M; Bamberger AM; Lüdecke DK; Beil FU; Saeger W; Schulte HM
    Eur J Endocrinol; 1999 Mar; 140(3):250-5. PubMed ID: 10216521
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression analysis of cyclins in pituitary adenomas and the normal pituitary gland.
    Turner HE; Nagy Z; Sullivan N; Esiri MM; Wass JA
    Clin Endocrinol (Oxf); 2000 Sep; 53(3):337-44. PubMed ID: 10971451
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential expression of galectin-3 in pituitary tumors.
    Riss D; Jin L; Qian X; Bayliss J; Scheithauer BW; Young WF; Vidal S; Kovacs K; Raz A; Lloyd RV
    Cancer Res; 2003 May; 63(9):2251-5. PubMed ID: 12727847
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential expression of cyclin D1 in human pituitary tumors: relation to MIB-1 and p27/Kip1 labeling indices.
    Hewedi IH; Osman WM; El Mahdy MM
    J Egypt Natl Canc Inst; 2011 Dec; 23(4):171-9. PubMed ID: 22776845
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunohistochemical analysis of p27 (Kip1) in human pituitary glands and in various types of pituitary adenomas.
    Komatsubara K; Tahara S; Umeoka K; Sanno N; Teramoto A; Osamura RY
    Endocr Pathol; 2001; 12(2):181-8. PubMed ID: 11579684
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic significance of p27KIP1 protein and ki-67 growth fraction in non-small cell lung cancers.
    Hommura F; Dosaka-Akita H; Mishina T; Nishi M; Kojima T; Hiroumi H; Ogura S; Shimizu M; Katoh H; Kawakami Y
    Clin Cancer Res; 2000 Oct; 6(10):4073-81. PubMed ID: 11051259
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of octreotide treatment on the proliferation and apoptotic index of GH-secreting pituitary adenomas.
    Losa M; Ciccarelli E; Mortini P; Barzaghi R; Gaia D; Faccani G; Papotti M; Mangili F; Terreni MR; Camanni F; Giovanelli M
    J Clin Endocrinol Metab; 2001 Nov; 86(11):5194-200. PubMed ID: 11701676
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Minichromosome maintenance protein 7 as prognostic marker of tumor aggressiveness in pituitary adenoma patients.
    Coli A; Asa SL; Fadda G; Scannone D; Chiloiro S; De Marinis L; Lauretti L; Ranelletti FO; Lauriola L
    Eur J Endocrinol; 2016 Mar; 174(3):307-14. PubMed ID: 26620390
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Results of immunohistochemical staining of cell-cycle regulators: the prediction of recurrence of functioning pituitary adenoma.
    Lee EH; Kim KH; Kwon JH; Kim HD; Kim YZ
    World Neurosurg; 2014; 81(3-4):563-75. PubMed ID: 24067736
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Levels of expression of p27KIP1 protein in human prostate and prostate cancer: an immunohistochemical analysis.
    Erdamar S; Yang G; Harper JW; Lu X; Kattan MW; Thompson TC; Wheeler TM
    Mod Pathol; 1999 Aug; 12(8):751-5. PubMed ID: 10463475
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic significance of p27/kip1 and apoptosis in patients with colorectal carcinoma.
    Noguchi T; Kikuchi R; Ono K; Takeno S; Moriyama H; Uchida Y
    Oncol Rep; 2003; 10(4):827-31. PubMed ID: 12792730
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Indices of apoptosis and proliferation as potential prognostic markers in non-functioning pituitary adenomas.
    Ibrahim AE; Pickering RM; Gawne-Cain ML; King S; Lees PD; Ellison DW
    Clin Neuropathol; 2004; 23(1):8-15. PubMed ID: 14986928
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Loss of p16 contributes to p27 sequestration by cyclin D(1)-cyclin-dependent kinase 4 complexes and poor prognosis in hepatocellular carcinoma.
    Matsuda Y; Ichida T; Genda T; Yamagiwa S; Aoyagi Y; Asakura H
    Clin Cancer Res; 2003 Aug; 9(9):3389-96. PubMed ID: 12960127
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of epidermal growth factor receptor in neoplastic pituitary cells: evidence for a role in corticotropinoma cells.
    Theodoropoulou M; Arzberger T; Gruebler Y; Jaffrain-Rea ML; Schlegel J; Schaaf L; Petrangeli E; Losa M; Stalla GK; Pagotto U
    J Endocrinol; 2004 Nov; 183(2):385-94. PubMed ID: 15531726
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictive markers of pituitary adenoma behavior.
    Kontogeorgos G
    Neuroendocrinology; 2006; 83(3-4):179-88. PubMed ID: 17047381
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cell cycle regulators in bladder cancer: a multivariate survival study with emphasis on p27Kip1.
    Korkolopoulou P; Christodoulou P; Konstantinidou AE; Thomas-Tsagli E; Kapralos P; Davaris P
    Hum Pathol; 2000 Jun; 31(6):751-60. PubMed ID: 10872671
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.